Results 261 to 270 of about 4,704,446 (291)
Some of the next articles are maybe not open access.

Robust Estimation for Average Treatment Effects

SSRN Electronic Journal, 2013
We study the probability tail properties of the Inverse Probability Weighting (IPW) estimators of the Average Treatment Effect T when there is limited overlap in the covariate distribution. Our main contribution is a new robust estimator that performs substantially better than existing IPW estimators.
openaire   +1 more source

Local Average Treatment Effect and Regression-Discontinuity-Design

2015
Local Average Treatment Effect and Regression-Discontinuity-Design for Program ...
Cerulli, G.
openaire   +3 more sources

Beyond the average treatment effect

Οι ιατρικές αποφάσεις συχνά βασίζονται στη μέση επίδραση θεραπειών όπως αυτή εκτιμάται από κλινικές δοκιμές, υποθέτοντας ότι όλοι οι ασθενείς επωφελούνται εξίσου. Ωστόσο, η προσέγγιση αυτή αγνοεί τη σημαντική ετερογένεια στις αντιδράσεις των ασθενών.
openaire   +1 more source

The average treatment effect and average partial effect in nonlinear models [PDF]

open access: possible, 2007
In the literature on program impact evaluation, the popular impact parameters can the average treatment effect, the average treatment effect on the treated, the average partial effect, and the average partial effect on the treated. In empirical studies, these parameters are not always presented and estimated clearly. In addition, when outcome functions
openaire  

Estimating average treatment effects in Stata [PDF]

open access: possible, 2007
In this talk, I look at several methods for estimating average effects of a program, treatment, or regime, under unconfoundedness. The setting is one with a binary program. The traditional example in economics is that of a labor market program where some individuals receive training and others do not, and interest is in some measure of the ...
openaire  

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

Ca-A Cancer Journal for Clinicians, 2017
Fernanda G Herrera   +2 more
exaly  

Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD

Nature Reviews Clinical Oncology, 2020
Bruce R Blazar   +2 more
exaly  

Home - About - Disclaimer - Privacy